SCHEMBL19475372

SCHEMBL19475372

Cc1cccc(-c2cc(CN3CCOCC3)c3ccccc3n2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 12/20 0.61
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
POLB P06746 2/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
ACP1 P24666 3/20 0.52
TSHR P16473 2/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AHR P35869 1/20 0.50
LMNA P02545 2/20 0.49
NPC1 O15118 1/20 0.49
HCRTR1 O43613 1/20 0.49
GAA P10253 1/20 0.49
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475464 0.81 MOK (0.59) MOKALDH1A1KDM4EPOLBMAPT
SCHEMBL19475336 0.81 MOK (0.67) MOKALDH1A1KDM4EMAPTACP1
SCHEMBL19475280 0.81 MOK (0.58) MOKALDH1A1KDM4EMAPTHPGD
SCHEMBL19508654 0.81 MOK (0.76) MOKACP1
SCHEMBL24975496 0.80 NCF1 (0.62) MOKALDH1A1KDM4EMAPTMEN1
SCHEMBL31428728 0.80 NCF1 (0.62) MOKALDH1A1KDM4EMAPTMEN1
SCHEMBL31590940 0.77 MOK (0.68) MOKACP1
SCHEMBL19475483 0.76 MOK (1.00) MOK
SCHEMBL28025651 0.76 MOK (0.69) MOKKDM4EACP1
SCHEMBL19475400 0.75 MOK (0.81) MOK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US claimed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO claimed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 MOK 4420/4885ALDH1A1 1885/4885KDM4E 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.